Thursday, November 6, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analysts Reaffirm Neutral Rating on Generac Holdings and Adjust Price Targets

Elaine Mendonca by Elaine Mendonca
February 12, 2024
in Breaking News
0
Gas Utilities Stock Market Today
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

On February 12, 2024, J.B. Lowe, an analyst at Citigroup, reaffirmed a Neutral rating on Generac Holdings (NYSE:GNRC) and increased the price target to $128. This adjustment was made in light of the company’s updated margin outlook. Another analyst at Citi, Vikram Bagri, also raised the price target on Generac Holdings to $128 from $124 while maintaining a Neutral rating. It is interesting to note that the average target price for Generac Holdings is $137.9, with a high estimate of $175 and a low estimate of $78. Furthermore, recent analysis indicates that analysts who have provided 12-month price targets for GNRC in the last 3 months have an average price target of $142.78, with a high estimate of $170 and a low estimate of $124.

Generac Holdings Inc. (GNRC) Shows Strong Performance with Impressive Stock Price Momentum on February 12, 2024

On February 12, 2024, Generac Holdings Inc. (GNRC) showcased a strong performance, based on the stock’s price momentum. According to data sourced from CNN Money, GNRC was trading in the middle of its 52-week range and above its 200-day simple moving average. The shares of GNRC witnessed an increase of $4.36 since the market last closed, resulting in a rise of 3.44%. Additionally, GNRC began the trading day at $126.91, which was in line with its previous closing price. Trading in the middle of its 52-week range indicates that GNRC has not reached its highest point in the past year, but it also hasn’t hit its lowest point. Furthermore, the fact that GNRC is trading above its 200-day simple moving average is a positive sign for investors. Overall, GNRC’s stock performance on February 12, 2024, was impressive. Investors will be keeping a close eye on GNRC as it continues to demonstrate its potential for growth in the market.

GNRC Stock Showcases Strong Financial Growth in 2023: Total Revenue, Net Income, and EPS Analysis

On February 12, 2024, GNRC stock showcased notable performances, reflecting the company’s financial achievements over the past year. By analyzing the data provided by CNN Money, we can gain insights into GNRC’s total revenue, net income, and earnings per share (EPS) for both the one-year and third-quarter periods.

Total revenue stood at $4.56 billion over the past year, indicating a significant increase of 22.14% compared to the previous year. This growth demonstrates GNRC’s ability to generate higher sales and potentially expand its market presence. Moreover, the company’s total revenue also experienced a positive 7.02% increase since the last quarter, indicating a consistent upward trend.

Net income stood at $350.27 million over the past year. Although this figure represents a decrease of 34.33% compared to the previous year, it is important to note that GNRC managed to reverse this trend in the third quarter. With a net income of $60.33 million, the company experienced a significant increase of 39.09% since the previous quarter. This improvement suggests that GNRC implemented effective strategies to enhance its profitability, leading to positive results in a relatively short period.

Earnings per share (EPS) stood at $5.42 over the past year. Although this represents a decrease of 34.77% compared to the previous year, GNRC managed to bounce back in the third quarter. With an EPS of $0.97, the company experienced a substantial increase of 39.66% since the previous quarter. This improvement indicates that GNRC’s profitability per share is on an upward trajectory, potentially attracting more investors.

Overall, GNRC’s stock performance on February 12, 2024, reflects positive financial growth in terms of total revenue, net income, and EPS. Despite a decrease in net income and EPS compared to the previous year, the company managed to reverse this trend in the third quarter, highlighting its ability to adapt and improve its financial performance. These positive indicators position GNRC as a potentially attractive investment option, as it demonstrates resilience and the potential for future growth. However, investors should conduct further research and analysis to make informed decisions based on their individual investment objectives and risk tolerance.

Tags: GNRC
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
eco friendly sustainable plan

Consumer Consciousness: The Demand for Ethical and Eco-Friendly Produce

Graduates

Unveiling the Success Stories of Adults Earning Diplomas Through Flexible Online Education

Investing in Health: The Growing Market for Allergy Therapeutics and Future Trends

Investing in Health: The Growing Market for Allergy Therapeutics and Future Trends

Recommended

Baidu Stock

Baidu’s Strategic Moves in Autonomous Driving and AI Draw Mixed Investor Reactions

1 month ago

Windtree Therapeutics Achieves Financial Stability and Advances Clinical Programs

2 years ago
Technology Data analytics Stock Bull Market

Anticipation High for Adobes FirstQuarter Financial Results and AI Innovation

2 years ago
Ideaya Biosciences Stock

Ideaya Biosciences: A Tale of Market Skepticism and Clinical Promise

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

EU Grant Provides Critical Boost for LanzaTech’s Carbon Recycling Technology

Is Darden Restaurants Facing a Critical Test?

Critical Juncture for USA Rare Earth as Earnings and Chinese Export Curbs Collide

AES Shares Surge on Potential $38 Billion Acquisition Speculation

Kura Oncology Investors Await Crucial FDA Verdict

Cadence Design Stock: A Battle Between Fundamentals and Market Signals

Trending

DuPont de Nemours Stock
Analysis

DuPont Faces Critical Test as Quarterly Results Loom

by Dieter Jaworski
November 6, 2025
0

DuPont de Nemours finds itself at a pivotal moment as the chemical giant prepares to release quarterly...

Sarepta Therapeutics Stock

Sarepta Therapeutics Shares Plummet Following Critical Clinical Trial Failure

November 6, 2025
Emerson Electric Stock

Emerson Electric’s Strategic Pivot Faces Market Scrutiny

November 6, 2025
Lanzatech Global Stock

EU Grant Provides Critical Boost for LanzaTech’s Carbon Recycling Technology

November 6, 2025
Darden Restaurants Stock

Is Darden Restaurants Facing a Critical Test?

November 6, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • DuPont Faces Critical Test as Quarterly Results Loom
  • Sarepta Therapeutics Shares Plummet Following Critical Clinical Trial Failure
  • Emerson Electric’s Strategic Pivot Faces Market Scrutiny

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com